Rashmi Mehta

Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD

Bartolomé R. Celli, Glenn Crater, Sally Kilbride et al. · CHEST Journal · 2014 · 155 citations

Umeclidinium/vilanterol 125/25, Pulmonary Care, Advanced Lung Disease +5

Umeclidinium in patients with COPD: a randomised, placebo-controlled study

Roopa Trivedi, Nathalie Richard, Rashmi Mehta et al. · European Respiratory Journal · 2013 · 91 citations · Full text

A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD

James F. Donohue, Antonio Anzueto, Jean Brooks et al. · Respiratory Medicine · 2012 · 65 citations

Novel Lama Gsk573719, Advanced Lung Disease, Pulmonary Medicine +3

Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients

Marc Decramer, François Maltais, Gregory Feldman et al. · Respiratory Physiology & Neurobiology · 2012 · 53 citations

Asthma, Advanced Lung Disease, Medicine +7

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Umeclidinium and Vilanterol Alone and in Combination: A Randomized Crossover Trial

Dennis Kelleher, Rashmi Mehta, Bernadette Jean-Francois et al. · PLoS ONE · 2012 · 43 citations · Full text